Clinical Trial Update: Efficacy of the EPIC Nitinol Vascular Stent System in Superficial Femoral Artery (SFA) Lesions

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating the EPIC Nitinol Vascular Stent System for superficial femoral artery lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis of the Femoral Artery
• Superficial Femoral Artery Stenosis

Snippet

Sponsor: Endovascular Consultoria Limitada | Conditions: Superficial Femoral Artery Stenosis, Atherosclerosis of Femoral Artery | Status: COMPLETED